The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis

Radiotherapy and Oncology

Volumn 116, Issue 1, 2015, Pages 38-44

  Borras, Josep M ^a   Lievens, Yolande ^b   Dunscombe, Peter ^c   Coffey, Mary ^d   Malicki, Julian ^e   Corral, Julieta ^f,g   Gasparotto, Chiara ^h   Defourny, Noemie ^h   Barton, Michael ⁱ   Verhoeven, Rob ^j   Van Eycken, Liesbeth ^k   Primic Zakelj, Maja ^l   Trojanowski, Maciej ^m   Strojan, Primoz ^l   Grau, Cai ⁿ  

^a UNIVERSITY OF BARCELONA   (Spain)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY OF CALGARY   (Canada)

^d TRINITY COLLEGE DUBLIN   (Ireland)

^e POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^f UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^g Catalonian Cancer Plan Department of Health   (Spain)

^h European SocieTy for Radiotherapy and Oncology   (Belgium)

ⁱ INGHAM INSTITUTE FOR APPLIED MEDICAL RESEARCH   (Australia)

^j Netherlands Cancer registry Netherlands Comprehensive Cancer Organisation   (Netherlands)

^k Belgian Cancer Registry   (Belgium)

^l INSTITUTE OF ONCOLOGY   (Slovenia)

^m GREATER POLAND CANCER CENTRE   (Poland)

ⁿ AARHUS UNIVERSITY HOSPITAL   (Denmark)

more..

Author keywords

European countries; Optimal utilization; Planning; Radiotherapy

Indexed keywords

ARTICLE; BELGIUM; BLADDER CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER REGISTRY; EUROPE; EVIDENCE BASED PRACTICE; EXTERNAL BEAM RADIOTHERAPY; HEALTH CARE UTILIZATION; HUMAN; KIDNEY CANCER; LARGE INTESTINE CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MELANOMA; MOUTH CANCER; NONHODGKIN LYMPHOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RUSSIAN FEDERATION; STOMACH CANCER; UTERUS CANCER; INCIDENCE; NEOPLASMS; PATHOLOGY;

EUROPE; HUMANS; INCIDENCE; NEOPLASMS;

EID: 84938954251     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2015.04.018     Document Type: Article

References (29)

1. G. Delaney, S. Jacob, C. Featherstone, and M. Barton The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines Cancer 104 2005 1129 1137
2. Erratum in: Cancer. 2006;107(3):660
3. M.B. Barton, S. Jacob, J. Shafiq, and et al. Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012 Radiother Oncol 112 2014 140 144
4. Borràs JM, Barton MB, Grau C, et al. Impact of cancer incidence and stage on the optimal utilization of radiotherapy: methodology of a population based analysis by ESTRO-HERO project. Radiother Oncol 2015;116:45-50.
5. J. Ferlay, E. Sterialova-Foucher, J. Lortet-Tieulent, and et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 Eur J Cancer 49 2013 1374 1403
6. C. Grau, N. Defourney, J. Malicki, and et al. Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO survey Radiother Oncol 112 2014 155 164
7. Y. Lievens, N. Defourny, M. Coffey, and et al. Radiotherapy staffing in the European countries: final results from the ESTRO-HERO survey Radiother Oncol 112 2014 178 186
8. P. Dunscombe, C. Grau, N. Defourny, and et al. Guidelines for equipment and staffing of radiotherapy facilities in the European countries: final results of the ESTRO-HERO survey Radiother Oncol 112 2014 165 177
9. Ingham Institute for Applied Medical Research (IIAMR) - Collaboration for Cancer Outcomes Research and Evaluation (CCORE). Review of optimal radiotherapy utilisation rates. CCORE report; 2013. Available from: tinyurl.com/pwkua34 [accessed 26-11-2014].
10. S. Siesling, A. Kwast, A. Gavin, P. Baili, and R. Otter EUROCHIP-3 Workpackage 5. Availability of stage at diagnosis, cancer treatment delay and compliance with cancer guidelines as cancer registry indicators for cancer care in Europe: results of EUROCHIP-3 survey Int J Cancer 132 2013 2910 2917
11. L. Asli, S. Kvaloy, V. Jetne, and et al. Utilization of radiation therapy in Norway after the implementation of the National cancer plan - A National, population-based study Int J Radiation Oncol Biol Phys 90 2014 707 714
12. R. Khor, M. Bressel, K.H. Tai, and et al. Patterns of retreatment with radiotherapy in a large academic centre J Med Imaging Radiother Oncol 57 2013 610 616
13. M.B. Barton, S. Allen, G.P. Delaney, and et al. Patterns of retreatment by radiotherapy Clin Oncol 26 2014 611 618
14. E. Rosenblatt, J. Izewska, Y. Anacak, and et al. Radiotherapy capacity in European countries: an analysis of the Directory of Radiotherapy Centres (DIRAC) database Lancet Oncol 14 2013 e79 e86
15. N.R. Datta, M. Samei, and S. Bodis Radiotherapy infrastructure and human resources in Europe: present status and its implications for 2020 Eur J Cancer 50 2014 2735 2743
16. S. Bentzen, G. Heeren, B. Cottier, and et al. Towards evidence based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTROQUARTS project Radiother Oncol 75 2005 355 365
17. R. De Angelis, M. Sant, M.P. Coleman, and et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study Lancet Oncol 15 2014 23 34
18. P.M.P. Poortmans, M.J. Aarts, J.J. Jobsen, and et al. A population based study on the utilisation of primary radiotherapy for prostate cancer in 4 regions in the Netherlands, 1997-2008 Radiother Oncol 99 2011 207 213
19. C.C.E. Koning, M.J. Aarts, H. Struikmans, and et al. Mapping the use of radiotherapy for patients with non-small cell lung cancer in the Netherlands between 1997-2008 Clin Oncol 24 2012 e46 e53
20. J.J. Jobsen, M.J. Aarts, S. Siesling, and et al. Use of primary radiotherapy for rectal cancer in the Netherlands between 1997 and 2008: a population based study Clin Oncol 24 2012 e1 e8
21. W.J. Mckillop Killing time: the consequences of delay in radiotherapy Radiother Oncol 84 2007 1 4
22. M. Popovic, M. den Hartog, L. Zhang, and et al. Review of international patterns of practice for the treatment of painful bone metastases with palliative radiotherapy from 1993 to 2013 Radiother Oncol 111 2014 11 17
23. A. Vulto, M. Louwman, P. Rodrigus, and J.W. Coebergh Referral rates and trends in radiotherapy as part of primary treatment of cancer in South Netherlands, 1998-2002 Radiolther Oncol 78 2006 131 137
24. N. Chawla, E.N. Butler, J. Lund, J.L. Warren, L.C. Harlan, and K.R. Yabroff Patterns of colorectal cancer care in Europe, Australia and New Zealand JNCI Monograph 46 2013 36 60
25. C. Goossens-Laan, A.M. Leliveld, R. Verhoeven, and et al. Effects of age and comorbidity on treatment and survival of patients with muscle invasive bladder cancer Int J Cancer 135 2014 905 912
26. M.J. Aarts, V.E. Lemmens, M.W. Louwman, A.E. Kunst, and J.W. Coebergh Socioeconomic status and changing inequalities in colorectal cancer? A review of the association with risk, treatment and outcome Eur J Cancer 46 2010 2681 2695
27. F. Fowler, M. Collins, P. Albertsen, and et al. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer JAMA 283 2000 3217 3222
28. B.L. Jacobs, Y. Zhang, T.A. Skolarus, and B.K. Hollenbeck Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse Health Affairs (Project Hope) 31 2012 750 759
29. Y. Lievens, W. Van den Bogaert, A. Rijnders, G. Kutcher, and K. Kesteloot Palliative radiotherapy practice within Western European countries: impact of the radiotherapy financing system? Radiother Oncol 56 2000 289 295